What is the best proton-pump inhibitor (PPI) for treating gastric erosions?

Best PPI for Gastric Erosions

All proton pump inhibitors (PPIs) are equally effective for treating gastric erosions, with no single agent demonstrating superior healing rates or clinical outcomes—choose based on cost, availability, and formulary considerations.

Evidence-Based Rationale

The available evidence does not support superiority of any specific PPI for gastric erosion treatment. A meta-analysis comparing PPIs for gastric ulcer healing found no conclusive evidence supporting one PPI over another 1, 2. The key distinction is between PPI class versus other agents (H2-receptor antagonists or placebo), not between individual PPIs.

PPI Class Superiority

PPIs as a class are significantly more effective than alternatives:

• vs. H2-receptor antagonists: PPIs achieve a pooled rate ratio of 1.33 (95% CI 1.24-1.42) for healing at 4 weeks 1
• vs. placebo: Substantially higher healing rates across all studies 1, 2
• H2RAs are less effective than PPIs for both symptom relief and healing rates of erosive disease 3

Standard Dosing Recommendations

For gastric erosions, use standard-dose PPI therapy:

• Omeprazole 20 mg daily (or equivalent)
• Lansoprazole 30 mg daily
• Pantoprazole 40 mg daily
• Rabeprazole 20 mg daily
• Esomeprazole 20-40 mg daily

Treatment duration: 4-8 weeks for gastric ulcers/erosions 2—longer than the 2-4 weeks typically needed for duodenal ulcers.

Clinical Decision Algorithm

1. Initial Treatment Selection

• Select any standard-dose PPI based on formulary/cost
• No need to preferentially choose one agent over another
• Pantoprazole may be preferred in elderly patients on multiple medications due to lower drug-drug interaction potential 4

2. Dosing Strategy

• Start with once-daily standard dosing
• Take 30-60 minutes before first meal of the day for optimal acid suppression
• Avoid twice-daily dosing unless severe erosive esophagitis (LA grade C/D) is present 5

3. Treatment Duration

• 4-8 weeks for gastric erosions 2
• Reassess at 8 weeks; consider endoscopic confirmation of healing if symptoms persist

4. Maintenance Therapy Considerations

• Do NOT continue long-term unless there is a definitive indication 5:
  • Severe erosive esophagitis (LA grade C/D)
  • Barrett's esophagus
  • High-risk NSAID users requiring gastroprotection
  • Recurrent disease documented on PPI cessation

Critical Pitfalls to Avoid

⚠️ Inappropriate long-term use: Gastric erosions typically heal within 4-8 weeks. Continuing PPIs beyond this without documented indication exposes patients to unnecessary risks (infections, fractures, kidney disease) 6

⚠️ Excessive dosing: Double-dose PPIs are not FDA-approved and lack RCT evidence for gastric erosions. Standard once-daily dosing is sufficient 5

⚠️ Failure to address underlying causes:

• Test for H. pylori and eradicate if positive (PPI + 2 antibiotics) 2
• Discontinue NSAIDs if possible, or add gastroprotection if continuation is necessary
• Address alcohol use and smoking

⚠️ Switching between PPIs without cause: If a patient fails standard-dose PPI therapy, the issue is likely not the specific PPI chosen but rather:

• Non-adherence to medication
• Continued NSAID use
• H. pylori not eradicated
• Incorrect diagnosis (not acid-related)

Special Populations

Pediatric patients: Omeprazole (0.7-3.3 mg/kg/day), lansoprazole (0.7-3.0 mg/kg/day), or esomeprazole are FDA-approved options 3. Use weight-based dosing and consider formulation (sprinkle capsules, oral suspension).

Elderly/polypharmacy: Pantoprazole has the lowest potential for drug-drug interactions 4

Bottom Line

Choose any standard-dose PPI for 4-8 weeks to treat gastric erosions. The specific agent matters less than ensuring appropriate dosing, adequate duration, addressing underlying causes (H. pylori, NSAIDs), and avoiding unnecessary long-term continuation. Titrate to the lowest effective dose or discontinue entirely once erosions heal unless a definitive long-term indication exists 5.